论文部分内容阅读
用有机锗（Ge－132）试验治疗荷移植肝癌小鼠。结果：De－132高剂量（12．5mg/次）治疗组的抑癌率为用31．0％，移植肝癌白细胞（WBC）浸润（＋＋＋）占72．7％、血清超氧化物歧化酶（SOD）活性为121Nu／ml，而生理盐水对照治疗组相应的后两项指标分别为用36．4％及81Nu／ml，两组比较有显著性差异（P＜0．05）；环磷酰胺（CTX）治疗组的抑癌率为37.0％，癌体WBC浸润（＋＋＋）为27.3％，血清SOD活性为102Nu／ml；ge-132高剂量与CTX2联合治疗组的抑癌率为45．0％，癌体WBC浸润（＋＋＋）为54．5％，血清SOD活性为142Nu/ml，两组比较，后二项指标有显著性差异（P＜0．05）。由此提示Ge-132高剂量能明显增强荷移植肝癌小鼠的细胞免疫及血清SOD活性，并有一定的抗移植肝癌作用。
The transplanted liver cancer mice were treated with the Ge-132 test. Results: The tumor suppressing rate of De-132 high-dose (12.5mg/times) treatment group was 31.0%, and the transplanted hepatocellular carcinoma white blood cells (WBC) infiltration (+++) accounted for 72.7%, serum superoxide dismutase ( The activity of SOD was 121 Nu/ml, while the corresponding two indexes of the normal saline control group were 36.4% and 81 Nu/ml, respectively. There was a significant difference between the two groups (P<0.05); Cyclophosphamide. The tumor suppressor rate of the (CTX) treatment group was 37.0%, the WBC infiltration (+++) of the cancer was 27.3%, the serum SOD activity was 102 Nu/ml; the tumor suppression rate of the high dose of ge-132 and CTX2 combined therapy group was 45.0 %, WBC infiltration of cancer (+++) was 54.5%, serum SOD activity was 142 Nu/ml, there was a significant difference between the two indicators (P<0.05). This suggests that high doses of Ge-132 can significantly enhance cellular immunity and serum SOD activity in transplanted liver cancer mice, and have a certain role in the anti-transplantation of liver cancer.